Osaka, Japan

Yuji Mino

This inventor holds 1 USPTO granted patent. Top assignee: Funai Yakuhin Kogyo Kabushiki Kaisha. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Mino. Retrieved from https://idiyas.com/inventor/yuji-mino-vvtvw9df

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuji Mino: Inventor of an Anti-Tumor Compound Patent.

Introduction

Yuji Mino is an inventor associated with Osaka, Japan, and Funai Yakuhin Kogyo Kabushiki Kaisha. His recorded patent concerns fluorouridine derivatives developed for potential use in anti-tumor agents.

Latest Patents

Mino is credited with 1 patent, titled “2'-Deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine derivatives, a process.” The patent describes derivatives with strong anti-tumor activity and weak toxicity. It also outlines a preparation process involving acylation with corresponding benzoyl halides and identifies the compounds as potential active ingredients for anti-tumor agents, especially those intended for oral administration.

Career Highlights

Mino’s documented patent work connects him with pharmaceutical research and the development of compounds intended to support cancer treatment. The patent’s description focuses on both the derivatives’ activity and their preparation.

Collaborations

Mino’s listed coworkers include Iwao Hashimoto and Masahiro Kawasaki. The patent information associates his work with Funai Yakuhin Kogyo Kabushiki Kaisha.

Conclusion

Yuji Mino’s recorded invention centers on fluorouridine derivatives proposed for anti-tumor use, reflecting a contribution to pharmaceutical innovation in Japan.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…